Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Non-Current Assets for 3 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 68.86% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.7 million for FY2025, 68.86% down from the prior year.
  • Non-Current Assets hit $3.7 million in Q4 2025 for Camp4 Therapeutics, down from $8.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $15.9 million in Q3 2024 to a low of $3.7 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $10.9 million across 3 years, with a median of $11.1 million in 2025.
  • Biggest five-year swings in Non-Current Assets: fell 20.15% in 2024 and later plummeted 68.86% in 2025.
  • Year by year, Non-Current Assets stood at $14.9 million in 2023, then dropped by 20.15% to $11.9 million in 2024, then tumbled by 68.86% to $3.7 million in 2025.
  • Business Quant data shows Non-Current Assets for CAMP at $3.7 million in Q4 2025, $8.7 million in Q3 2025, and $10.2 million in Q2 2025.